<DOC>
	<DOCNO>NCT00368303</DOCNO>
	<brief_summary>The study investigate non-inferior efficacy Paroxetine Controlled Release Paroxetine Immediate Release , well drug tolerability profile treat patient Major Depression .</brief_summary>
	<brief_title>A Local Register Study For Major Depression Of Paroxetine Controlled Release</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Paroxetine</mesh_term>
	<criteria>Patients Major Depressive Disorder , score depression rating scale reach specific point ( 17 item Hamilton Depression Scale &gt; 18 ) . Exclusion criterion : patient use monoamine oxidase inhibitor ( MAOIs ) , benzodiazepine , Chinese herbal medicine , acupuncture , moxibustion psychoactive medication zolpidem , zopiclone ; diagnose Axis I disorder ; responsive paroxetine therapy ; pregnant lactating , serious medical disorder condition would preclude administration paroxetine ; history seizure disorder ( except febrile seizure childhood ) ; require treatment warfarin anticoagulant , phenytoin , cimetidine , sumatriptan , type 1C antiarrhythmic , quinidine sulfonylurea derivative ; substance abuse dependence ( alcohol drug ) within 6 month prior trial ; electroconvulsive therapy within 2 month entry study ; pose current , serious suicidal homicidal risk ; take psychotropic drug antidepressant MAO inhibitor within 7 day baseline MAO inhibitor within 14 day baseline ; take investigational drug , participate clinical trial within past 3 month ; hypersensitivity paroxetine ; undergo formal psychotherapy/psychoanalysis .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2011</verification_date>
	<keyword>Major Depression</keyword>
	<keyword>paroxetine control release ( CR )</keyword>
	<keyword>paroxetine immediate release ( IR )</keyword>
</DOC>